Clinical trial
Use of Cannabinoids in Patients With Multiple Sclerosis
NCT00202423 · S. Andrea Hospital, Other · Unknown status
Key facts
| NCT number | NCT00202423 |
|---|---|
| Title | Use of Cannabinoids in Patients With Multiple Sclerosis |
| Official title | fMRI and Neurophysiological Study Protocol on Cannabinoids in Multiple Sclerosis |
| Lead sponsor | S. Andrea Hospital, Other |
| Collaborators | University of Roma La Sapienza |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Sativex |
| Enrollment | 20 |
| Start date | Jul 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 29, 2005 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: